Patients
In this trial, 186 participants completed the study, including 94 in the placebo group and 92 in the Jinlida group. There was no statistically significant difference in HbA1c, FBG, 2hPG, body weight, and BMI between Jinlida and placebo groups at baseline. Demographic information of subjects has been reported previously (The symptom assessment of subjects in the treatment and control groups at baseline.